Aarskog-Scott Syndrome

What is Aarskog-Scott Syndrome?

Aarskog-Scott syndrome is a rare genetic condition that mainly affects males. It causes distinct changes in physical appearance, including short stature (being shorter than expected for one's age), facial differences, and abnormalities of the hands, feet, and genitals.

The condition is also called faciogenital dysplasia. "Dysplasia" means that certain body parts did not develop in the typical way. Boys with this syndrome are often shorter than their peers and may have a wide, rounded face with widely spaced eyes and a small nose.

In addition to physical features, some individuals with Aarskog-Scott syndrome experience mild learning or behavioral differences, though intellectual ability is usually within the normal range. The condition was first described by physicians Dagfinn Aarskog and Charles Scott in the 1970s.

What is the prevalence of Aarskog-Scott Syndrome?

Aarskog-Scott syndrome is considered rare. Because the condition is often mild or variable in how it appears, it may be underdiagnosed — meaning some people may have the condition without knowing it. Exact worldwide prevalence figures are not firmly established in the medical literature.

The condition predominantly affects males. Females who carry the genetic change may show very mild features or none at all.

How is Aarskog-Scott Syndrome diagnosed?

Diagnosis is based primarily on a physical examination and the recognition of typical features. Doctors look for a combination of short stature, a particular facial appearance, and characteristic hand and genital findings. No single feature alone confirms the diagnosis.

Genetic testing can confirm the diagnosis by identifying changes (called mutations or variants) in the FGD1 gene. However, not all individuals with the clinical features of Aarskog-Scott syndrome have a detectable FGD1 change, which suggests that other genetic factors may also be involved.

A specialist in genetics or pediatric endocrinology (a doctor who focuses on hormones and growth) is often involved in confirming the diagnosis and guiding care.

Is there any specific virus or pathway in Aarskog-Scott Syndrome that has been identified?

Yes. Aarskog-Scott syndrome is caused by changes in the FGD1 gene, which is located on the X chromosome (one of the chromosomes that determines biological sex). Because males have only one X chromosome, a single mutation in FGD1 is enough to cause the condition. Females have two X chromosomes, so they are usually protected by having a working copy on the other chromosome.

The FGD1 gene provides instructions for making a protein that helps control cell shape and movement during development. This protein is part of a signaling pathway (a chain of molecular signals inside cells) that regulates the Rho family of proteins, which are important for the proper growth and organization of tissues.

Researchers continue to study why not all patients with classic features have FGD1 mutations, pointing to possible involvement of additional genes or regulatory regions.

How is Aarskog-Scott Syndrome treated?

There is no cure for Aarskog-Scott syndrome. Treatment focuses on managing specific symptoms and supporting overall development. Care is tailored to the individual, since the severity of features varies widely.

Short stature may be monitored by a pediatric endocrinologist. In some cases, growth hormone therapy has been considered, though evidence for its effectiveness in this specific syndrome is limited. Dental and orthodontic (teeth and jaw alignment) care is often needed due to dental crowding.

If there are behavioral or learning difficulties, educational support, speech therapy, or occupational therapy may be helpful. Surgical correction may be considered for certain physical features, such as undescended testes (testes that have not moved into their usual position). Regular follow-up with a team of specialists is important.

Are there any clinical trials underway for Aarskog-Scott Syndrome?

Because Aarskog-Scott syndrome is rare and often presents mildly, few dedicated clinical trials exist. Specific trial counts for this condition could not be verified from available sources at the time this page was prepared.

Individuals interested in research opportunities may wish to search ClinicalTrials.gov using the term "Aarskog-Scott syndrome" and consult with a genetics specialist who may be aware of research registries or observational studies.

How can RareShare be helpful to Aarskog-Scott Syndrome patients and families?

RareShare can help people affected by Aarskog-Scott syndrome connect with other patients, caregivers, and families, share lived experiences, and learn about community resources. Current RareShare community statistics could not be verified. These discussions can support connection, education, and ongoing access to shared experiences and resources.

Sources

  1. National Institutes of Health, Genetic and Rare Diseases Information Center (GARD). "Aarskog-Scott syndrome." NIH GARD. https://rarediseases.info.nih.gov/diseases/5382/aarskog-scott-syndrome

  2. National Organization for Rare Disorders (NORD). "Aarskog Syndrome." NORD Rare Disease Database. https://rarediseases.org/rare-diseases/aarskog-syndrome/

  3. MedlinePlus, U.S. National Library of Medicine. "Aarskog-Scott syndrome." MedlinePlus Genetics. https://medlineplus.gov/genetics/condition/aarskog-scott-syndrome/

  4. Orrico A, Galli L, Cavaliere ML, et al. "Phenotypic and molecular characterisation of the Aarskog-Scott syndrome: a survey of the clinical variability in light of FGD1 mutation analysis in 46 patients." European Journal of Human Genetics. 2004;12(1):16–23.

  5. Pasteris NG, Cadle A, Logie LJ, et al. "Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor." Cell. 1994;79(4):669–678.

  6. Online Mendelian Inheritance in Man (OMIM). "Faciogenital Dysplasia; FGDY." Entry #305400. https://omim.org/entry/305400

  7. Orphanet. "Aarskog-Scott syndrome." Orphanet Encyclopedia. https://www.orpha.net/